Jason Alger is Chief Financial Officer of Health Catalyst, Inc.. Currently has a direct ownership of 86,712 shares of HCAT, which is worth approximately $601,781. The most recent transaction as insider was on Mar 07, 2022, when has been sold 461 shares (Common Stock) at a price of $25.14 per share, resulting in proceeds of $11,590. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 86.7K
24.01% 3M change
66.99% 12M change
Total Value Held $601,781

Jason Alger Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 07 2022
SELL
Open market or private sale
$11,590 $25.14 p/Share
461 Reduced 1.19%
38,179 Common Stock
Mar 02 2022
SELL
Payment of exercise price or tax liability
$4,190 $26.69 p/Share
157 Reduced 0.4%
38,640 Common Stock
Mar 01 2022
SELL
Payment of exercise price or tax liability
$25,618 $26.63 p/Share
962 Reduced 2.52%
37,246 Common Stock
Mar 01 2022
BUY
Grant, award, or other acquisition
-
1,551 Added 3.84%
38,797 Common Stock
Feb 24 2022
BUY
Grant, award, or other acquisition
-
25,000 Added 39.55%
38,208 Common Stock
Dec 06 2021
SELL
Open market or private sale
$25,007 $38.83 p/Share
644 Reduced 4.65%
13,208 Common Stock
Dec 02 2021
SELL
Payment of exercise price or tax liability
$61,247 $41.95 p/Share
1,460 Reduced 9.54%
13,852 Common Stock
Sep 03 2021
SELL
Open market or private sale
$35,358 $54.23 p/Share
652 Reduced 4.08%
15,312 Common Stock
Sep 01 2021
SELL
Payment of exercise price or tax liability
$15,510 $54.23 p/Share
286 Reduced 1.76%
15,964 Common Stock
Jun 03 2021
SELL
Open market or private sale
$35,079 $52.75 p/Share
665 Reduced 3.93%
16,250 Common Stock
Jun 01 2021
SELL
Payment of exercise price or tax liability
$14,655 $53.88 p/Share
272 Reduced 1.58%
16,915 Common Stock
Apr 13 2021
SELL
Open market or private sale
$315,491 $50.07 p/Share
6,301 Reduced 26.83%
17,187 Common Stock
Mar 04 2021
SELL
Open market or private sale
$28,294 $47.0 p/Share
602 Reduced 2.5%
23,488 Common Stock
Mar 01 2021
SELL
Payment of exercise price or tax liability
$16,504 $49.12 p/Share
336 Reduced 1.38%
24,090 Common Stock
Feb 18 2021
BUY
Grant, award, or other acquisition
-
15,000 Added 38.05%
24,426 Common Stock
Jan 14 2021
BUY
Exercise of conversion of derivative security
$67,610 $10.73 p/Share
6,301 Added 40.06%
9,426 Common Stock
JA

Jason Alger

Chief Financial Officer
South Jordan, UT

Track Institutional and Insider Activities on HCAT

Follow Health Catalyst, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HCAT shares.

Notify only if

Insider Trading

Get notified when an Health Catalyst, Inc. insider buys or sells HCAT shares.

Notify only if

News

Receive news related to Health Catalyst, Inc.

Track Activities on HCAT